Section Arrow
BFRI.NASDAQ
- Biofrontera
(Financial Status)
Quotes are at least 15-min delayed:2025/07/05 14:33 EDT
Last
 0.7
+0.0099 (+1.43%)
Day High 
0.725 
Prev. Close
0.6901 
1-M High
0.755 
Volume 
106.86K 
Bid
0.7
Ask
0.72
Day Low
0.6999 
Open
0.71 
1-M Low
0.5526 
Market Cap 
6.52M 
Currency USD 
P/E 0.74 
%Yield -- 
10-SMA 0.65 
20-SMA 0.64 
50-SMA 0.67 
52-W High 2.22 
52-W Low 0.536 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.81/0.17
Enterprise Value
10.89M
Balance Sheet
Book Value Per Share
0.05
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
37.32M
Operating Revenue Per Share
3.07
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands0.5387+0.0535+11.03%-- 
RGCRegencell Bioscience Holdings Limited22.99+12.63+121.91%-- 
CGCCanopy Growth Corp1.28+0.09+7.56%-- 
IXHLIncannex Healthcare0.2094+0.0025+1.21%-- 
HLNHaleon plc10.25-0.01-0.10%23.95PE
Quotes are at least 15-min delayed:2025/07/05 14:33 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products,which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.